Skip to main content

Table 1 Characteristics of patients and treatments

From: Absolute volume of the rectum and AUC from rectal DVH between 25Gy and 50Gy predict acute gastrointestinal toxicity with IG-IMRT in prostate cancer

  All patients
N = 180
Age (median [range]) years 70.5 [49.6–84.9]
T stage-n (%)
 T1c 57 (31.7 %)
 T2a 31 (17.2 %)
 T2b 37 (20.6 %)
 T2c 19 (10.6 %)
 T3a 30 (16.7 %)
 T3b 6 (3.3 %)
PSA (ng/ml) (median [range]) 10 [0.8–99]
Gleason score-n (%)
  ≤ 6 103 (57.2 %)
 7 64 (35.6 %)
  ≥ 8 13 (7.2 %)
Risk groups-n (%)
 Low risk 48 (26.7 %)
 Intermediate risk 68 (37.8 %)
 High risk 64 (35.6 %)
Hormone therapy-n (%)
 Neoadjuvant 50 (27.8 %)
 Concomitant 69 (38.3 %)
 Adjuvant 70 (38.9 %)
Radiotherapy: prostate dose (2Gy/fxa) 78 [70–80]
Median [range]
TURPb-n (%)
 Yes 35 (19.7 %)
 No 143 (80.3 %)
 Missing 2 (1.1 %)
  1. a fraction; b transurethral resection of the prostate